Literature DB >> 16408100

Increase of CCR7- CD45RA+ CD8 T cells (T(EMRA)) in chronic graft-versus-host disease.

M D'Asaro, F Dieli, N Caccamo, M Musso, F Porretto, A Salerno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16408100     DOI： 10.1038/sj.leu.2404079

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

Authors:  Sophie Paczesny; Frances T Hakim; Joseph Pidala; Kenneth R Cooke; Julia Lathrop; Linda M Griffith; John Hansen; Madan Jagasia; David Miklos; Steven Pavletic; Robertson Parkman; Estelle Russek-Cohen; Mary E D Flowers; Stephanie Lee; Paul Martin; Georgia Vogelsang; Marc Walton; Kirk R Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-30       Impact factor: 5.742

2.  Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.

Authors:  Jacob Rozmus; Kirk R Schultz; Kristin Wynne; Amina Kariminia; Preeti Satyanarayana; Mark Krailo; Stephan A Grupp; Andrew L Gilman; Frederick D Goldman
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-25       Impact factor: 5.742

3.  A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.

Authors:  Yue Liu; Aijie Huang; Qi Chen; Xiaofei Chen; Yang Fei; Xiaoming Zhao; Weiping Zhang; Zhanying Hong; Zhenyu Zhu; Jianmin Yang; Yifeng Chai; Jianmin Wang; Xiaoxia Hu
Journal:  JCI Insight       Date:  2019-07-25

Review 4.  The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis.

Authors:  Nardhy Gomez-Lopez; Jose Galaz; Derek Miller; Marcelo Farias-Jofre; Zhenjie Liu; Marcia Arenas-Hernandez; Valeria Garcia-Flores; Zachary Shaffer; Jonathan M Greenberg; Kevin R Theis; Roberto Romero
Journal:  Reproduction       Date:  2022-06-20       Impact factor: 3.923

Review 5.  Biologic markers of chronic GVHD.

Authors:  J Pidala; M Sarwal; S Roedder; S J Lee
Journal:  Bone Marrow Transplant       Date:  2013-07-22       Impact factor: 5.483

6.  Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling.

Authors:  Tom Erkers; Helen Kaipe; Silvia Nava; Pia Molldén; Britt Gustafsson; Rimma Axelsson; Olle Ringdén
Journal:  Stem Cells Dev       Date:  2015-01-15       Impact factor: 3.272

7.  Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis.

Authors:  Wei Liu; Han-Yun Ren; Yu-Jun Dong; Li-Hong Wang; Yue Yin; Yuan Li; Zhi-Xiang Qiu; Xi-Nan Cen; Yong-Jin Shi
Journal:  Int J Hematol       Date:  2012-11-23       Impact factor: 2.490

8.  T Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves.

Authors:  L Barbarash; I Kudryavtsev; N Rutkovskaya; A Golovkin
Journal:  Mediators Inflamm       Date:  2016-02-17       Impact factor: 4.711

Review 9.  B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mateja Kralj Juric; Maxim Shevtsov; Petra Mozes; Justyna Ogonek; Rachel E Crossland; Anne M Dickinson; Hildegard T Greinix; Ernst Holler; Eva M Weissinger; Gabriele Multhoff
Journal:  Front Immunol       Date:  2017-01-16       Impact factor: 7.561

10.  Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.

Authors:  Guro Kristin Melve; Elisabeth Ersvaer; Geir Egil Eide; Einar K Kristoffersen; Øystein Bruserud
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.